Alglucosidase alfa vs placeboQoL (PCS in SF‐36 (measured on a scale from 0 to 100)) · 90 people with LOPD1 finding from 1 reviewEnzyme replacement therapy for late‐onset Pompe disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 90 participantsLow